Latest Market News

Proteomics International will take Promarker D and Promarker Eso nationwide through Healius from 26 October, extending its first commercial release beyond Western Australia and the Northern Territory. The tests will initially be offered privately at $495 and $997, while revenue remains too uncertain to forecast.

Fenix Resources has monetised most of its iron ore swap book for more than A$10 million, converting protection on 480,000 tonnes into near-term cash. The move leaves the company retaining diesel and currency hedges while restoring exposure to prevailing iron ore prices on the settled tonnes.

Alkane Resources delivered 40,740 gold equivalent ounces in the September quarter, generated A$102 million in mine operating cash flow and reaffirmed FY27 production guidance. The result also funded the company’s maiden dividend while leaving A$440 million in cash and bullion.

BluGlass has expanded its customer-funded GaN laser programs with a A$1.4 million Uviquity contract and a new A$286,000 photonics collaboration. But its A$8 million facility is fully drawn, carries 16.5% interest and leaves reported funding coverage at 2.8 quarters.

Zip delivered strong first-quarter growth, with total transaction volume up 18% to A$4.6 billion, but a US fraud event cost A$10.1 million and pushed group net bad debts higher. The company nevertheless reaffirmed its A$340 million FY27 cash EBTDA target, with September momentum offering an early test of whether the disruption was temporary.

Temple & Webster is holding to its FY27 EBITDA target of $33 million to $40 million even as revenue fell 8% in the first months of the year. The online retailer says reduced discounting is depressing sales but improving contribution margins, while AI, private-label products and brand investment move from testing into rollout.

Peet delivered record FY26 earnings as its proposed sale to Ingenia moves through the approval process. Profit rose 77% to $103.4 million, while contracts on hand climbed to $850.7 million and the fully franked dividend increased to 13 cents per share.

Bhagwan Marine reported $81.3 million in Q1 FY27 revenue, up 32% on the prior corresponding period, as subsea services and Riverside Industrial Sands led a stronger start to the year. Recurring revenue also increased to 64%, while new subsea awards and a Riverside Guardian contract added to the growth pipeline.

Black Cat Syndicate maintained its FY27 production and cost guidance despite a capital-heavy quarter that pushed cash and liquid investments down by A$27.7 million. Paulsens remained steady, while Kal East’s ramp-up and a new A$30 million cash improvement program now dominate the execution story.

Argent BioPharma ended the September quarter with just A$11,000 in cash after A$734,000 of operating outflows, despite retaining A$7.4 million of unused convertible financing capacity. The company is simultaneously expanding its commercial portfolio through NLC antiviral rights and a CannEpil veterinary programme.

Vita Resources will seek up to A$500,000 from eligible Australian and New Zealand shareholders at A$0.021 a share, a 4.5% discount to its recent market price. The non-underwritten offer is intended to fund Ninnis exploration and further gold opportunities, but the final amount raised remains uncertain.

IKE has lowered its previously indicated FY27 subscription revenue growth expectation of about 35%, citing contract timing rather than weaker demand or churn. The NZX and ASX-listed software company still expects its subscription exit run rate to grow by more than 30% by March 2027, while three new products remain on track for launch.